Effectiveness of the Quotient® ADHD Assessment in a System of Care

Kaiser Permanente

Status: Terminated

Conditions: Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder With Hyperactivity

Treatments: Device: Quotient®; Behavioral: Usual Clinic ADHD Care

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02094612

Quotient ADHD (Other Identifier)

CN-13-1692-H

Details and patient eligibility

About

The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.

Full description

This study is a randomized, controlled trial using a 2-phase data collection. The first phase is the initial assessment for ADHD and includes all patients eligible to be assessed for ADHD as determined by their clinician in the course of usual care. The baseline measurements will be used to compare groups at baseline, and also for longitudinal analyses of medication management. Patients are randomized at this point. Patients in both treatment arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible for the second phase of the study: three follow-up assessments over six months. Patients who do not have an ADHD diagnosis will not continue in the study, and will be treated by their clinician as usual.

Enrollment: 207 patients

Sex: All

Ages: 6 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients within the specified age range who are English speaking and who are presenting for ADHD assessment are eligible. An additional criterion is consent to be randomized.

Exclusion criteria

• Non English speaking
• Refusal to participate

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

207 participants in 2 patient groups

Usual Care

Active Comparator group

Description:

Usual clinic ADHD care

Treatment:

Behavioral: Usual Clinic ADHD Care

Usual Care plus Assessment

Experimental group

Description:

Usual clinic ADHD care plus the Quotient®

Treatment:

Device: Quotient®